PMV Pharmaceuticals Inc. (PMVP) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

PMV Pharmaceuticals Inc. (PMVP)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

1.35

-0.04 (-2.88%)

At close: Jan 14, 2025, 3:59 PM

1.35

0.00%

Pre-market Jan 15, 2025, 07:44 AM EST

undefined% (undefined)

Bid	1.31
Market Cap	69.86M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-1
PE Ratio (ttm)	-1.35
Forward PE	n/a
Analyst	Buy

Ask	1.39
Volume	181,272
Avg. Volume (20D)	199,203
Open	1.40
Previous Close	1.39
Day's Range	1.35 - 1.50
52-Week Range	1.35 - 2.26
Beta	undefined

About PMVP

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing mutant p53 programs, including Wild-type p53 Induced-Phosphatase, R282W, and R273H, as well a...

[Show more]

Industry Biotechnology

Sector Healthcare

IPO Date Sep 25, 2020

Employees 63

Stock Exchange NASDAQ

Ticker Symbol PMVP

Website https://www.pmvpharma.com

Analyst Forecast

According to 3 analyst ratings, the average rating for PMVP stock is "Buy." The 12-month stock price forecast is $5, which is an increase of 270.37% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Why Price Moved

10 months ago · Source

+1.62%

PMV Pharmaceuticals shares are trading higher afte... Unlock content with Pro Subscription

News

7 months ago · zacks.com

Here's Why PMV Pharmaceuticals (PMVP) Could be Great Choice for a Bottom Fisher

PMV Pharmaceuticals (PMVP) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement ...

7 months ago · businesswire.com

Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator

BOSTON & PRINCETON, N.J.--(BUSINESS WIRE)--Foundation Medicine and PMV Pharma partner to develop FoundationOne®CDx as a companion diagnostic for PMV Pharma's rezatapopt.

1 year ago · seekingalpha.com

PMV Pharmaceuticals: In A Stronger Position Now Than Before, At A Lower Price

PMV Pharmaceuticals' phase 1/2 trial of its drug, PC14586, in solid tumors with a Y220C p53 mutation produced initial data in 2022, but the response was mixed. A 2023 update on data from the phase 1/2...

1 year ago · zacks.com

PMV Pharmaceuticals, Inc. (PMVP) Loses -70.19% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for PMV Pharmaceuticals, Inc. (PMVP) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall ...

1 year ago · zacks.com

Wall Street Analysts See a 239.26% Upside in PMV Pharmaceuticals, Inc. (PMVP): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 239.3% in PMV Pharmaceuticals, Inc. (PMVP). While the effectiveness of this highly sought-after metric is quest...

1 year ago · zacks.com

Wall Street Analysts Think PMV Pharmaceuticals, Inc. (PMVP) Could Surge 182.64%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 182.6% in PMV Pharmaceuticals, Inc. (PMVP). While the effectiveness of this highly sought-after metric is quest...

1 year ago · zacks.com

PMV Pharmaceuticals, Inc. (PMVP)'s Technical Outlook is Bright After Key Golden Cross

After reaching an important support level, PMV Pharmaceuticals, Inc. (PMVP) could be a good stock pick from a technical perspective. PMVP recently experienced a "golden cross" event, which saw its 50-...

2 years ago · finbold.com

Top 10 most-shorted stocks as of November 2022

The difficult state of the macroeconomic environment in 2022 has had a negative impact on the performance of a number of equity investments. Worries about a recession and a bearish attitude among inve...

2 years ago · zacks.com

PMV Pharmaceuticals, Inc. (PMVP) Upgraded to Buy: Here's What You Should Know

PMV Pharmaceuticals, Inc. (PMVP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

2 years ago · investorplace.com

Halted Stocks: 9 Circuit Breaker Stocks That Have Been Halted on Tuesday

We've seen a large array of halted stocks today as circuit breakers take effect to reign in unexpected volatility for some shares. The post Halted Stocks: 9 Circuit Breaker Stocks That Have Been Halte...